Background Studies regarding the impact of Parkinson's disease (PD) on quality of life
(QOL) have reported conflicting results, and the underlying QOL domains require further …

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or globus pallidum internus
(GPi) improves motor functions in patients with Parkinson's disease (PD) but may cause a …

Introduction The globus pallidus internus (GPi) region has evolved as a potential target for
deep brain stimulation (DBS) in Parkinson's disease (PD). DBS of the GPi (GPi DBS) is an …

Importance Comparative outcomes among different monogenic forms of Parkinson disease
after subthalamic nucleus deep brain stimulation (STN DBS) remain unclear. Objective To …

Background Subthalamic (STN) and pallidal (GPi) deep brain stimulation (DBS) improve
quality of life, motor, and nonmotor symptoms (NMS) in advanced Parkinson's disease (PD) …

Genetic subtyping of patients with Parkinson's disease (PD) may assist in predicting the
cognitive and motor outcomes of subthalamic deep brain stimulation (STN‐DBS). Practical …

The treatment of Parkinson's disease (PD) is challenging, especially since it is considered
highly individualized. The Brazilian Academy of Neurology has recognized the need to …

Background: Inflammation contributes substantially to the pathogenesis of Parkinson's
disease (PD). Plasma extracellular vesicle (EV)-derived cytokines are emerging biomarkers …

OBJECTIVE Pain is the most common nonmotor symptom of Parkinson's disease (PD) and
is often undertreated. Deep brain stimulation (DBS) effectively mitigates the motor symptoms …

Parkinsonism and Parkinson's disease are not synonymous. Parkinsonism refers classically
to a triad of motor symptoms (bradykinesia, rigidity, and tremor), but gait instability is also …